GlassScriptPhysician profile
Vibha Agrawal
NPI 1528196045
$1,499.15
in general payments reported to CMS, 2019-2025
15 companies · $430 in 2025
The $430 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.19 · 2021: $20.52 · 2022: $52.59 · 2023: $358 · 2024: $545 · 2025: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,332.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $515.63 | 2023-2025 | Licart, Tirosint, Tirosint |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $262.76 | 2019-2025 | Relistor |
| Vertex Pharmaceuticals Incorporated | $207.05 | 2024-2025 | |
| Virtus Pharmaceuticals LLC | $111.25 | 2023-2025 | Levorphanol Tartrate |
| Collegium Pharmaceutical, INC. | $93.25 | 2023-2025 | Belbuca |
| Biotronik Nro, INC. | $58.08 | 2024-2025 | Prospera |
| Abbvie INC. | $48.67 | 2023-2024 | Qulipta |
| Scilex Pharmaceuticals INC. | $40.59 | 2019-2024 | |
| Nalu Medical, INC. | $37.07 | 2024 | Nalu Neurostimulation System |
| Nevro Corp. | $25.41 | 2022 | |
| Boston Scientific Corporation | $23.38 | 2019-2022 | |
| Assertio Therapeutics, INC. | $22.94 | 2019 | |
| Biodelivery Sciences International, INC. | $20.52 | 2021 | |
| Lilly USA, LLC | $17.93 | 2019 | |
| Depuy Synthes Sales INC. | $14.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vibha Agrawal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.